bucladesine and Respiratory Distress Syndrome

bucladesine has been researched along with Respiratory Distress Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, ML; Chen, HI; Hsu, K; Wang, D; Wu, CP1
Chiang, CH; Hsu, CS; Hsu, K; Huang, KL; Wang, D1

Other Studies

2 other study(ies) available for bucladesine and Respiratory Distress Syndrome

ArticleYear
Pulmonary edema induced by phorbol myristate acetate is attenuated by compounds that increase intracellular cAMP.
    Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 1996, Volume: 196, Issue:1

    Topics: Adrenergic beta-Agonists; Aminophylline; Animals; Blood Pressure; Bucladesine; Capillary Permeability; Cyclic AMP; Disease Models, Animal; Humans; Lung; Lung Injury; Male; Neutrophils; Phosphodiesterase Inhibitors; Pulmonary Artery; Pulmonary Edema; Rabbits; Respiratory Distress Syndrome; Terbutaline; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha

1996
Dibutyryl cAMP prevents increased vascular permeability caused by air embolism in isolated rat lungs.
    Aviation, space, and environmental medicine, 1997, Volume: 68, Issue:9

    Topics: Aerospace Medicine; Aminophylline; Animals; Bronchodilator Agents; Bucladesine; Capillary Permeability; Drug Evaluation, Preclinical; Embolism, Air; Extravehicular Activity; In Vitro Techniques; Lung; Male; Pentoxifylline; Pulmonary Wedge Pressure; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Time Factors; Vasodilator Agents

1997